Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-26

FDA Approved: LACOSAMIDE — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ANI Pharmaceuticals' Original Abbreviated New Drug Application for lacosamide, authorizing the marketing of a generic lacosamide product. Lacosamid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (generic) (Lacosamide)

Snippet

ORIG AP for LACOSAMIDE (LACOSAMIDE)